SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001618835-23-000004
Filing Date
2023-01-10
Accepted
2023-01-10 08:38:02
Documents
14
Period of Report
2023-01-10
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K evfm-20230110.htm   iXBRL 8-K 34217
2 EX-99.1 a20230110_evfmxcostcoxfina.htm EX-99.1 10572
6 GRAPHIC image_0a.jpg GRAPHIC 27428
  Complete submission text file 0001618835-23-000004.txt   220752

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT evfm-20230110.xsd EX-101.SCH 1896
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT evfm-20230110_lab.xml EX-101.LAB 23892
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT evfm-20230110_pre.xml EX-101.PRE 12519
8 EXTRACTED XBRL INSTANCE DOCUMENT evfm-20230110_htm.xml XML 10798
Mailing Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130
Business Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130 (858) 550-1900
Evofem Biosciences, Inc. (Filer) CIK: 0001618835 (see all company filings)

IRS No.: 208527075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36754 | Film No.: 23519757
SIC: 2834 Pharmaceutical Preparations